Veracity Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

Veracity Capital LLC

$271 Million
Q4 2024

A detailed history of Veracity Capital LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Veracity Capital LLC holds 5,614 shares of REGN stock, worth $3.95 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares

5,614

Previous 5,672 1.02%

Holding current value

$3.95 Million

Previous $5.96 Million 32.93%

% of portfolio

1.48%

Previous 2.28%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$701.85 - $1046.91 $40,707 - $60,720	-58 Reduced 1.02%	5,614 $4 Million
Q3 2024 Oct 18, 2024	SELL	$1024.09 - $1201.76 $143,372 - $168,246	-140 Reduced 2.41%	5,672 $5.96 Million
Q2 2024 Jul 22, 2024	SELL	$883.2 - $1071.19 $273,792 - $332,068	-310 Reduced 5.06%	5,812 $6.11 Million
Q1 2024 Apr 19, 2024	SELL	$902.69 - $993.35 $217,548 - $239,397	-241 Reduced 3.79%	6,122 $5.89 Million
Q4 2023 Jan 22, 2024	SELL	$775.18 - $881.7 $80,618 - $91,696	-104 Reduced 1.61%	6,363 $5.59 Million
Q3 2023 Oct 25, 2023	SELL	$692.45 - $844.37 $35,314 - $43,062	-51 Reduced 0.78%	6,467 $5.32 Million
Q2 2023 Jul 20, 2023	BUY	$700.03 - $830.35 $11,900 - $14,115	17 Added 0.26%	6,518 $4.68 Million
Q1 2023 Apr 06, 2023	SELL	$680.49 - $826.97 $199,383 - $242,302	-293 Reduced 4.31%	6,501 $5.34 Million
Q4 2022 Jan 17, 2023	SELL	$705.89 - $766.39 $102,354 - $111,126	-145 Reduced 2.09%	6,794 $0
Q3 2022 Oct 17, 2022	BUY	$573.97 - $724.32 $1,147 - $1,448	2 Added 0.03%	6,939 $4.78 Million
Q2 2022 Jul 18, 2022	SELL	$548.35 - $738.84 $60,318 - $81,272	-110 Reduced 1.56%	6,937 $4.1 Million
Q1 2022 Apr 18, 2022	SELL	$595.12 - $698.43 $131,521 - $154,353	-221 Reduced 3.04%	7,047 $4.92 Million
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $20,108 - $24,825	37 Added 0.51%	7,268 $4.59 Million
Q3 2021 Oct 13, 2021	SELL	$574.03 - $680.96 $304,235 - $360,908	-530 Reduced 6.83%	7,231 $4.38 Million
Q2 2021 Jul 22, 2021	SELL	$472.8 - $558.54 $58,627 - $69,258	-124 Reduced 1.57%	7,761 $4.34 Million
Q1 2021 Apr 12, 2021	SELL	$446.73 - $548.2 $314,051 - $385,384	-703 Reduced 8.19%	7,885 $3.73 Million
Q4 2020 Jan 25, 2021	BUY	$478.3 - $607.98 $189,406 - $240,760	396 Added 4.83%	8,588 $4.15 Million
Q3 2020 Oct 21, 2020	BUY	$544.75 - $658.21 $87,704 - $105,971	161 Added 2.0%	8,192 $4.59 Million
Q2 2020 Jul 13, 2020	SELL	$493.32 - $643.92 $4.05 Million - $5.28 Million	-8,205 Reduced 50.54%	8,031 $5.01 Million
Q1 2020 May 07, 2020	SELL	$336.18 - $494.43 $365,091 - $536,950	-1,086 Reduced 6.27%	16,236 $7.93 Million
Q4 2019 May 07, 2020	BUY	$274.13 - $376.51 $4.75 Million - $6.52 Million	17,322 New	17,322 $6.5 Million

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veracity Capital LLC with notifications on news.

Account

Veracity Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History